Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Wrap Technologies (WRAP): Is a +57% Climb to $2.00 Realistic?

Wrap Technologies (WRAP): Is a +57% Climb to $2.00 Realistic?

Key Takeaways

  • The $2.00 target discussed here is not an analyst consensus. It is a fallback objective drawn from publicly discussed technical levels and round-number resistance, reflecting the absence of credible, current analyst price targets for WRAP.
  • At a latest verified close near $1.27, reaching $2.00 would require a gain of roughly 57%, a very large move for a micro-cap stock.
  • There is effectively no usable analyst coverage: TipRanks lists zero covering analysts, MarketBeat reports no consensus price target, and the only visible rating is a "Sell" from Weiss Ratings, which does not publish a numeric target.
  • The strongest support for a recovery is revenue growth, insider buying, a low-debt balance sheet, and the company's counter-drone (WrapShield) and recurring "program" strategy.
  • The biggest risks are persistent losses, heavy share-based compensation, dilution, declining margins, and management's own acknowledgment that its $10 million 2026 revenue goal may not be reached.
  • For more detail, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers can also explore Trending AI Robots for automated market analysis tools.

Where the $2.00 Target Originates

WRAP lacks sufficient current analyst price targets for any meaningful consensus. Older targets from Ladenburg Thalmann, such as reductions to $5.25 and $6.75, date back to 2022 and no longer hold relevance. Data providers show no valid consensus at present. In the absence of reliable analyst figures, the $2.00 level serves as a practical reference drawn from visible technical commentary rather than formal research.

Independent technical services have highlighted upside zones around $1.89 and $2.01, with one source listing $2.50 and MarketScreener pointing to resistance near $2.46. The $2.00 round number also previously functioned as support before the stock fell below it in 2026. Rounding these zones to $2.00 creates a straightforward benchmark roughly 57% above the recent price.

Current Standing and the Route to the Target

At the most recent verified close, WRAP sat near $1.27 after an 8% single-session drop and about 50% decline over the past year. Its 52-week range runs from roughly $0.98 to $3.23. A move to $2.00 would demand an increase of around 57% for a company with an approximate $85 million market capitalization. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Any sustained advance would likely hinge on operational progress rather than multiple expansion. The company remains unprofitable, showing a trailing gross margin near 63% alongside deeply negative operating margins. Durable improvement would require turning product sales and the pipeline into higher-margin recurring revenue while demonstrating traction on WrapShield and multi-year agency programs.

Factors That Could Support Progress

Nine-month revenue increased about 43% to roughly $4.7 million, fueled by a 174% rise in product sales. Insider buying has appeared, which often signals confidence from those closest to the business. The balance sheet looks relatively clean with modest cash and limited debt, lowering immediate solvency concerns. The shift toward bundled “Operationalizing De-Escalation” programs at around $100 per officer per month, combined with the WrapShield counter-UAS platform, could expand the market. Senate language favoring non-lethal technology adds a potential policy benefit, though without attached funding.

Obstacles That Could Block the Target

Challenges remain significant. The company continues posting losses, with the Q3 net loss widening from a year earlier and substantial non-cash share-based compensation adding to expenses. Management has noted that the $10 million 2026 revenue goal may prove difficult as larger orders have slipped. Gross margins have softened as lower-margin hardware sales grow in proportion, and recurring revenue, renewals, and customer adoption are still unproven. The share count rose roughly 10% year over year, introducing dilution. Short interest exceeds 12% of shares outstanding, and the stock trades below both its 50-day and 200-day moving averages.

Technical Levels and Market Structure

The chart presents a cautious picture. The 50-day moving average lies near $1.39 and the 200-day near $1.55, so the stock would need to reclaim these before $2.00 looks attainable. Mid-term resistance sits around $2.46, and $2.00 itself represents former support that could now act as resistance. On the downside, the $0.98-to-$1.06 zone marks recent lows and key support. The longer-term structure stays in a downtrend, meaning any rally would first require a firm break above the $1.55-to-$1.60 area.

Time Horizon and Key Items to Watch

Without active analyst coverage, the $2.00 reference carries no standard 12-month horizon and functions best as a technical marker. Investors should monitor quarterly earnings and revenue trends, gross-margin direction, cash burn and dilution, bookings and pipeline conversion, plus any WrapShield commercialization updates. Policy moves on non-lethal funding and potential new analyst coverage would also matter.

Leveraging AI Tools for Additional Perspective

In my own process, I often review Tickeron's AI Daily Buy/Sell Signals alongside traditional analysis. The platform applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market conditions and technical shifts. For a micro-cap name like this, it offers an efficient way to track changes that might otherwise require extensive manual effort.

Final Assessment

The $2.00 objective is not a published analyst forecast but a reference point based on publicly noted technical levels and round-number resistance, positioned about 57% above the latest price. Achieving it would demand a substantial re-rating for a company that is expanding revenue yet still unprofitable, diluting shares, and operating in a downtrend. The positive case centers on recurring-revenue conversion and counter-drone progress, while risks include ongoing losses, margin pressure, and execution questions. No consensus view exists, and outcomes are not assured. Focus remains on the next earnings release, cash-burn and dilution patterns, and whether the stock can reclaim its moving averages as an early indicator of a more lasting shift.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WRAP

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


WRAP's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for WRAP turned positive on November 09, 2026. Looking at past instances where WRAP's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where WRAP's RSI Indicator exited the oversold zone, 27 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

Following a +22.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where WRAP advanced for three days, in 159 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 41 cases where WRAP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WRAP as a result. In 99 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WRAP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

WRAP broke above its upper Bollinger Band on November 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for WRAP entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.462) is normal, around the industry mean (1.448). P/E Ratio (-4.214) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (13.680) is also within normal values, averaging (32.028).

The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. WRAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WRAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -2%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -21%. SVRE experienced the highest price growth at 99%, while ARBE experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 203%. For the same stocks of the Industry, the average monthly volume growth was 388% and the average quarterly volume growth was 229%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: 7 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an industrial conglomerate which manufactures law enforcement products

Industry ElectronicEquipmentInstruments

Industry
Industrial Conglomerates
Address
3350 Virginia Street
Phone
+1 800 583-2652
Employees
25
Web
https://www.wrap.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.